Chemotherapy options in elderly and frail patients with metastatic colorectal cancer (MRC FOCUS2): an open-label, randomised factorial trial-Reference-Cited by-同舟云学术

Chemotherapy options in elderly and frail patients with metastatic colorectal cancer (MRC FOCUS2): an open-label, randomised factorial trial

Published:2011-05 Issue:9779 Volume:377 Page:1749-1759
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Seymour Matthew T,Thompson Lindsay C,Wasan Harpreet S,Middleton Gary,Brewster Alison E,Shepherd Stephen F,O'Mahony M Sinead,Maughan Timothy S,Parmar Mahesh,Langley Ruth E

Funder

the UK National Cancer Research Institute Colorectal Clinical Studies Group, funded by Cancer Research UK

Publisher

Elsevier BV

Subject

General Medicine

Reference30 articles.

1. Estimates of the cancer incidence and mortality in Europe in 2006;Ferlay;Ann Oncol,2007

2. Cancer facts and figures, 2006,2006

3. Irinotecan/fluorouracil combination in first-line therapy of older and younger patients with metastatic colorectal cancer: combined analysis of 2691 patients in randomized controlled trials;Folprecht;J Clin Oncol,2008

4. Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer;De Gramont;J Clin Oncol,2000

5. Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial;Douillard;Lancet,2000

Cited by 359 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Geriatric Assessment-guided therapy modification and outcomes in patients with non-metastatic gastroesophageal cancer: a retrospective cohort study;ESMO Gastrointestinal Oncology;2024-12

2. Phase 1 clinical trials in refractory colorectal cancer: Do older patients benefit?;Journal of Geriatric Oncology;2024-09

3. Oxaliplatin Added to Fluoropyrimidine/Bevacizumab as Initial Therapy for Unresectable Metastatic Colorectal Cancer in Older Patients: A Multicenter, Randomized, Open-Label Phase III Trial (JCOG1018);Journal of Clinical Oncology;2024-08-26

4. DOSAGE study: protocol for a phase III non-inferiority randomised trial investigating dose-reduced chemotherapy for advanced colorectal cancer in older patients;BMJ Open;2024-08

5. Reply to Y.-Y. Qiu et al;Journal of Clinical Oncology;2024-07-24